Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in china: a modelling analysis

HIGHLIGHTS

• who: Xiaozhen Lai from the This study is ufb01rst subnational economic analysis in ChinaChina Center for Health Development Studies, Peking University, Beijing, China have published the research work: Estimating national, regional and provincial cost-effectiveness of introducing childhood 13-valent pneumococcal conjugate vaccination in China: a modelling analysis, in the Journal: (JOURNAL)
• what: Implications of all the available evidence the study provides reliable subnational estimates of the costeffectiveness of PCV13 introduction in China. The authors focused on the first five years after the cohort`s birth, when most costs and gains occurred, and calculated life . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.